RT inhibitors as microbicides KU Leuven
© 2013 Springer Science+Business Media New York. All rights are reserved. More than 50 % of HIV-infected people live in developing countries. Most of them do not have easy access to highly active antiretroviral therapy (HAART). It seems unlikely that an efficient vaccine against HIV will be available within a reasonable time frame, if ever possible at all. Therefore, the development of a widely available microbicide that efficiently prevents ...